| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 34 |
| 1 | METHOTREXATE SODIUM | 27 |
| 2 | METHOTREXATE | 26 |
| 3 | RITUXIMAB | 26 |
| 4 | OCRELIZUMAB | 20 |
| 5 | ETANERCEPT | 19 |
| 6 | CYCLOPHOSPHAMIDE | 18 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 9 | GOLIMUMAB | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 1 | GOLIMUMAB | 18 | 0.0014 |
| 2 | IDELALISIB | 7 | 0.0010 |
| 3 | THYROTROPIN ALFA | 1 | 0.0010 |
| 4 | TRIMIPRAMINE | 1 | 0.0009 |
| 5 | CLEMASTINE FUMARATE | 1 | 0.0007 |
| 6 | BENDAMUSTINE HCL | 9 | 0.0006 |
| 7 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 8 | GADOTERIDOL | 1 | 0.0006 |
| 9 | OBINUTUZUMAB | 9 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 8 | 0.0005 |
| 2 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Tetracycline-class Drug [EPC] | 10 | 0.0001 |
| 5 | Aromatase Inhibitor [EPC] | 16 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 44 | 0.0001 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 8 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 18 | 0.0001 |